Skip to main content

Eli Lilly is worried that the Novo-Catalent deal could dent its ability to make drugs

By The Wall Street Journal  
   February 07, 2024

Executives have concerns about Novo Holdings' purchase of contract manufacturer Catalent because Catalent helps produce certain Lilly products.

Full story


Get the latest on healthcare leadership in your inbox.